Latham & Watkins advised 4D Molecular Therapeutics, while Cooley advised the underwriters for the offering.4D Molecular Therapeutics, Inc. has announced that it priced an upsized underwritten…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Pietro Martinoia
…
This content is for Standard 1 Year members only. LoginJoin Now